2006 Minnesota Statutes

246.721 PROTOCOL FOR EXPOSURE TO BLOODBORNE PATHOGENS.
(a) A secure treatment facility shall follow applicable Occupational Safety and Health
Administration guidelines under Code of Federal Regulations, title 29, part 1910.1030, for
bloodborne pathogens.
(b) Every secure treatment facility shall adopt and follow a postexposure protocol for
employees at a secure treatment facility who have experienced a significant exposure. The
postexposure protocol must adhere to the most current recommendations of the United States
Public Health Service and include, at a minimum, the following:
(1) a process for employees to report an exposure in a timely fashion;
(2) a process for an infectious disease specialist, or a licensed physician who is
knowledgeable about the most current recommendations of the United States Public Health
Service in consultation with an infectious disease specialist, (i) to determine whether a significant
exposure to one or more bloodborne pathogens has occurred, and (ii) to provide, under the
direction of a licensed physician, a recommendation or recommendations for follow-up treatment
appropriate to the particular bloodborne pathogen or pathogens for which a significant exposure
has been determined;
(3) if there has been a significant exposure, a process to determine whether the patient has a
bloodborne pathogen through disclosure of test results, or through blood collection and testing as
required by sections 246.71 to 246.722;
(4) a process for providing appropriate counseling prior to and following testing for a
bloodborne pathogen regarding the likelihood of bloodborne pathogen transmission and follow-up
recommendations according to the most current recommendations of the United States Public
Health Service, recommendations for testing, and treatment;
(5) a process for providing appropriate counseling under clause (4) to the employee of a
secure treatment facility and to the patient; and
(6) compliance with applicable state and federal laws relating to data practices,
confidentiality, informed consent, and the patient bill of rights.
History: 2000 c 422 s 51